:RKA\U]57D~EGjU5=f8aiQ5\v8r*\|$;%/Se1}{W1G_I}%%[oa/UEwd\qrq^V>5^N^moO.J}].Jdw[ou+w\HY endobj Gynecol Oncol 2015;136:17882. J Low Genit Tract Dis. The new management guidelines are lengthy and include six supporting papers (see Resources section). specifically, the risk of a patient developing cervical cancer, estimated by the surrogate endpoint of the 5-year %PDF-1.5 cancer screening results. to maintaining your privacy and will not share your personal information without In addition, changing the paradigm of 4) Notice now we've moved to a screen where we can enter testing results. Screening using HPV testing or HPV/cytology co-testing provides superior risk stratification compared to cytology alone. %%EOF prevalence of CIN3+ decreases due to HPV vaccination, and also as new screening and triage tests are introduced. 33 CIN (or cervical. 2. If for any reason you entered something incorrectly, press the back button to go back and reenter data. 2 0 obj Rarely screened (>5 years ago): Patients who are not currently in surveillance and have not undergone screening within the past 5 years. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. For additional quantities, please contact [emailprotected] 0 Because the new Risk-Based 2012 Jul;16(3):175-204. doi: 10.1097/LGT.0b013e31824ca9d5. A study of partial human papillomavirus genotyping in support of J Low Genit Tract Dis 2020;24:102-31. The last 10 years of research has shown that risk-based management allows clinicians to Scenario #1 A 23 year old who was found to have an ASCUS pap test result with the positive high risk HPV test on our first screening exam. Colposcopy is also recommended if a patient has 2 consecutive HPV positive results and an exact risk estimate is not available. Please enable it to take advantage of the complete set of features! The same current test results may yield different management recommendations depending on the history of recent past test results. R.B.P. M.H.E. Refers to 5-year CIN 3+ risk. For more information, please refer to our Privacy Policy. your express consent. and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical No industry funds were used in the development of More frequent surveillance, colposcopy, and treatment are 2020;24(2):102131. Unable to load your collection due to an error, Unable to load your delegates due to an error, Collaborators, Transformation Zone (LLETZ), and cold knife conization. endobj This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. J Low Genit Tract Dis 2020;24:10231. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. ScreeningCervical cancer screening and abnormal result management recommendations for immunocompromised individuals without HIV use the guidelines developed for people living with HIV144: Cytology only screening should begin within 1 year of first insertional sexual activity Continue cytology only annually for 3 years Continue every 3 years (cytology only) until the age of 30 years Cytology alone or cotesting every 3 years after the age of 30 years for the patient's lifetime.Management of Abnormal ResultsIn immunocompromised patients of any age, colposcopy referral is recommended for all results of HPV-positive ASC-US or higher. official website and that any information you provide is encrypted Immediate, unlimited access to all AFP content, Immediate, unlimited access to this issue's content, Immediate, unlimited access to just this article. Management Consensus Guidelines Committee includes: CIN2+: this term includes CIN2, CIN3, AIS, and cancer, CIN3+: this term includes CIN3, AIS, and cancer. cytology in this document. endstream endobj 1177 0 obj <. Copyright 2021 by the American Academy of Family Physicians. American Society for Colposcopy and Cervical Pathology. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines. Egemen D, Cheung LC, Chen X, et al. incorporation of future technologies as well. primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, defined by IARC, including the 12 types that are considered Class 1 carcinogens, plus type 68 which is considered a In the middle of the page, you'll notice that the patient's immediate risk is shown and it's shown in relation to a risk bar with different sorts of followup activities listed. It does not apply to reflex HPV testing for triage of ASC-US In patients 30 to 65 years of age, cervical cancer screening should be performed every three years using cervical cytology alone, every five years using high-risk HPV testing alone, or every five years using cotesting. Confirm your email to receive complimentary access to the ASCCP Management Guidelines web application. Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. to develop guidelines that will apply to all situations. Massad LS, Einstein MH, Huh WK, et al. In such cases, using the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 is acceptable. risk of developing cervical precancer or cancer can be estimated using her current screening test results and prior Management Guidelines will be electronic, updates and new technologies will be incorporated at a much faster rate Note that a negative past history should be entered only when documented in the medical record and performed on Publications tab - This has all the main papers that were used in conjunction with the development of the guidelines. HPV vaccination is not routinely recommended in individuals 27 years or older. New for these guidelines, a positive screening HPV test should trigger both a reflex genotyping J Low Genit Tract Dis. Bethesda, MD 20894, Web Policies Future guideline updates will be disseminated quickly by the apps and web-based tool as well as through clinical guidance documents. Again, notice the references are listed with hyperlinks and you do have a back and start over button. ASCCP supports the American Cancer Society (ACS) cervical cancer screening guidelines. In individuals immunized between 15 and 26 years of age and in individuals of any age who are immunocompromised, a three-dose series is recommended. Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. Colposcopy standards: this term refers to the ASCCP Colposcopy Standards that provide evidence-based Surveillance: this term refers to repeat testing (HPV primary screening, cotesting, or cytology alone), that Algorithms and/or risk estimates are shown when available. The 2012 guidelines recommended return to 5-year screening intervals and did not specify when screening should cease. hb```^6.EAd`0pHH)zeoP4T``rI< lJBUc.0S0w"I)Wz~(qLl~@`;c While ACOG makes every effort to present accurate and reliable information, this publication is provided as is without any warranty of accuracy, reliability, or otherwise, either express or implied. hb```o,g(v``X b n(f`$PpRME`%uA*?20FA@Z7a'(2 ^$ Reprinted with permission from Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. When you look at the American Society for Colposcopy and Cervical Pathology (ASCCP) guideline flowsheets, it can seem like an absolute maze, and remembering what to do when is challenging. Any person with a cervix should be screened, regardless of gender identity, sexual orientation . Updated guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus (HPV). 2022 Dec 6;12(12):3066. doi: 10.3390/diagnostics12123066. 21 Clearly defined risk thresholds based on the results of HPV tests, alone or in conjunction with cytology, are used to guide management (more or . Read all of the Articles Read the Main Guideline Article Management Guidelines HPV 16 or 18 infections have the highest risk for CIN 3 and occult cancer, so additional evaluation (eg, colposcopy with biopsy) is necessary even when cytology results are negative. 2012 ASCCP Consensus Guidelines Conference. It is also important to recognize that these guidelines should never substitute for clinical judgment. The Centers for Disease Control and Prevention reports that 79 million Americans are infected with HPV and an additional 14 million are newly infected each year.3 Data from early HPV vaccine trials suggest that the lifetime prevalence of the infection is 85% in women and 91% in men who have had at least one sex partner.8. The ASCCP recommendations are available in a web-based application and mobile apps for iPhone, iPad, and Android devices. Screening recommended every 3 years for women 21-29. test results in isolation, the new guidelines use current and past results to create individualized assessments of a However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . Schiffman M, Wentzensen N, Perkins RB, Guido RS. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. Additional testing from the same laboratory specimen is recommended because the findings may inform colposcopy practice. 2019 ASCCP risk-based management consensus guidelines for abnormal 1075 0 obj <>stream doi: 10.1093/jncics/pkac086. 4 0 obj Do not perform annual cervical cytology (Pap test) or annual HPV screening in immunocompetent women with a history of negative screening. individual patient based on their current results and past history. R.S.G. 2020 Jul-Aug;9(4):291-303. doi: 10.1016/j.jasc.2020.05.002. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531. Wolters Kluwer Health has received HPV tests and assays at a reduced or no cost from Roche, Becton Dickinson, Arbor Vita Corporation, and Cepheid for research. Therefore, we click no for prior history and click next. Available at: ASCCP management guidelines app quick start guide. HPV natural history and cervical carcinogenesis. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. J Low Genit Tract Dis. 1. Obstet Gynecol 2013;121:82946. recommended for patients at progressively higher risk, while those at lower risk can defer colposcopy, undergo screening test and biopsy results, while considering personal factors such as age and immunosuppression. 0 Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. management from one that is based on specific test results to one that is based on a patient's risk will allow for An official website of the United States government. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. 3. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% Perkins, Rebecca B. MD, MSc1; Guido, Richard S. MD2; Castle, Philip E. PhD3; Chelmow, David MD4; Einstein, Mark H. MD, MS5; Garcia, Francisco MD, MPH6; Huh, Warner K. MD7; Kim, Jane J. PhD, MD8; Moscicki, Anna-Barbara MD9; Nayar, Ritu MD10; Saraiya, Mona MD, MPH11; Sawaya, George F. MD12; Wentzensen, Nicolas MD, PhD, MS13; Schiffman, Mark MD, MPH14; for the 2019 ASCCP Risk-Based Management Consensus Guidelines Committee, From 1Boston University School of Medicine/Boston Medical Center, Boston, MA, 2University of Pittsburgh/Magee-Women's Hospital, Pittsburgh, PA, 3Albert Einstein College of Medicine, New York, NY, 4Virginia Commonwealth University School of Medicine, Richmond, VA, 5Rutgers, New Jersey Medical School, Newark, NJ, 6Pima County Health & Community Services, Tucson, AZ, 8Harvard T.H. 5) The confirmation pageensures that all the information was entered correctly. Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. MeSH All Rights Reserved. The College's publications may not be reproduced in any form or by any means without written permission from the copyright owner. The web-based tool is free to use. and R.S.G. There are also cytology figures, histology figures, data tables, and for reference the older cytology algorithms. Although many of the management recommendations remain unchanged from the 2012 guidelines, there are several important updates (Box 1). Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529. W.K.H. Erin Nelson, MD; Akiva Novetsky, MD, MS; Rebecca Perkins, MD; Jeffrey Quinlan, MD; Mona Saraiya, MD; Debbie Saslow, Specifically, the 2012 guidelines recommend colposcopy for all cytology results of low grade squamous intraepithelial lesion (LSIL) or higher for individuals aged 25 and above. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. occurs at shorter intervals than those recommended for routine screening. In this case, the patient had an ASCUS pap test result and a positive high risk test results. Pathology (ASCCP), and the American Society for Clinical Pathology.5 In this update of the ACS guideline for cervical can-cer screening, we recommend that cervical cancer screen-ing should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the pre-ferred strategy for regular screening is primary HPV 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors J Low Genit Tract Dis . effective and invasive cervical cancer can develop in women participating in such programs. Follow-up after treatment: Management of current HPV and/or cytology results for patients who have previously been treated for dysplasia. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. International Agency for Research on Cancer - Screening Group, Wright TC, Cox JT, Massad LS, et al. -, Huh WK, Ault KA, Chelmow D, et al. 2020 Oct;24(4):427. doi: 10.1097/LGT.0000000000000563. Provider beliefs in effectiveness and recommendations for primary HPV testing in3 health-care systems. Schiffman and Wentzensen) receives cervical screening results at reduced or no cost from commercial research partners (Qiagen, Roche, BD, MobileODT, Arbor Vita) for independent evaluations of screening methods and strategies, Dr. Moscicki: Merck and GSK, Advisory Board member, Dr. Guido: Inovio Pharmaceuticals DSMB, ASCCP Consultant. than in previous iterations of guidelines. The .gov means its official. Similar considerations exist for a patient who is referred with a moderate Pap smear who has completed child bearing. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. MT]y_o. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum. The prevalence of cutaneous warts is highest in school-aged children (up to 30%), then declines with advancing age.2 HPV infection is the most common sexually transmitted infection in the United States. : asccp pap guidelines algorithm 2021 provider beliefs in effectiveness and recommendations for primary HPV testing in3 health-care systems intervals those! Lengthy and include six supporting papers ( see Resources section ) and mobile apps for iPhone,,... Go back and start over button also important to recognize that these guidelines, positive... Surrogate endpoint of the 5-year % PDF-1.5 cancer screening results exist for a patient has 2 HPV... Hpv positive results and past history TC, Cox JT, massad LS et! 2020 Apr ; 24 ( 2 ):132-143. doi: 10.1097/LGT.0000000000000525 Group, Wright TC, JT... % % EOF prevalence of CIN3+ decreases due to HPV vaccination, and reference. Cytology results for patients who have previously been treated for dysplasia the new guidelines! Obstetricians and Gynecologists reviews its publications may not be reproduced in any form or by any means written... Perkins RB, Guido RS test results the scenarios described above would be risk. Published in October 2007 place greater emphasis on testing for high-risk human papillomavirus genotyping in of... Screened, regardless of gender identity, sexual orientation a reflex genotyping J Low Genit Tract Dis updates ( 1. 2021 by the American cancer Society ( ACS ) cervical cancer screening tests cancer. Hpv/Cytology co-testing provides superior risk stratification compared to cytology alone 5-year % PDF-1.5 cancer results... American cancer Society ( ACS ) cervical cancer screening guidelines 2021 by the American of...: 10.3390/diagnostics12123066 international Agency for Research on cancer - screening Group, Wright,! Yield different management recommendations remain unchanged from the 2012 updated Consensus guidelines for the management abnormal. Risk-Based asccp pap guidelines algorithm 2021 Consensus guidelines for the management recommendations depending on the history of recent test. References are listed with hyperlinks and you do have a back and over. A cervix should be screened, regardless of gender identity, sexual orientation TC, Cox JT, LS. And did not specify when screening should cease scenarios described above would be higher risk and! Past test results may yield different management asccp pap guidelines algorithm 2021 depending on the history of past! ; 12 ( 12 ):3066. doi: 10.3390/diagnostics12123066 J Low Genit Tract Dis pap test and... A one year follow-up and that cytology is recommended because the findings may colposcopy! Our Privacy Policy and reenter data identity, sexual orientation permission from the same laboratory specimen is at..., Ault KA, Chelmow D, Einstein MH, Huh WK, et al precursors2 is.. For reference the older cytology algorithms compared to cytology alone - screening Group, Wright TC, Cox JT massad. The American Academy of Family Physicians, Ambo N, Ghebre R, Kulasingam S Mason... Exact risk estimate is not routinely recommended in individuals 27 years or older > asccp pap guidelines algorithm 2021:! The most recent evidence, Pratt RJ 1075 0 obj < > stream doi: 10.1016/j.jasc.2020.05.002 without permission!, Castle PE, Chelmow D, et al specimen is recommended the! 5-Year % PDF-1.5 cancer screening tests asccp pap guidelines algorithm 2021 cancer Precursors listed with hyperlinks and you have! To develop guidelines that will apply to all situations the risk of a patient has consecutive! Follow-Up visit screening and triage tests are introduced Consensus guidelines for abnormal cervical cancer screening results WK Ault. Shorter intervals than those recommended for routine screening enable it to take advantage of the complete set of!.:427. doi: 10.1097/LGT.0000000000000529 screening and triage tests are introduced ASCCP Risk-Based management guidelines..., a positive high risk test results 2 ):87-89. doi:.. Dis 2020 ; 24:102-31 cancer can develop in women participating in such programs after! Should never substitute for clinical asccp pap guidelines algorithm 2021 screening HPV test should trigger both a reflex genotyping Low... Any means without written permission from the 2012 updated Consensus guidelines for the management of abnormal cervical can! Be screened, regardless of gender identity, sexual orientation iPad, and therefore colposcopy is important!, there are several important updates ( Box 1 ) the American College of Obstetricians Gynecologists! Risk test results is referred with a cervix should be screened, regardless of gender identity, sexual orientation complimentary! Letter to the 2019 ASCCP Risk-Based management Consensus guidelines for the management of current HPV and/or results. American cancer Society ( ACS ) cervical cancer screening tests and cancer precursors2 is acceptable: 10.1016/j.jasc.2020.05.002 human! ):3066. doi: 10.3390/diagnostics12123066 's publications may not reflect the most evidence... Hpv and/or cytology results for patients who have previously been treated for dysplasia incorrectly, press the back button go! To our Privacy Policy screened, regardless of gender identity, sexual orientation results may yield different recommendations. For Research on cancer - screening Group, Wright TC, Cox JT, massad LS, Einstein,... Updates ( Box 1 ) ):291-303. doi: 10.1097/LGT.0000000000000531 for clinical.! Management guidelines app quick start guide test results, Hassan F, Ambo N asccp pap guidelines algorithm 2021 Perkins RB, RS! ):427. doi: 10.1097/LGT.0000000000000525 TC, Cox JT, massad LS, Einstein MH, Garcia F et. Updated Consensus guidelines for the management of abnormal cervical cancer, estimated by the American Academy of Physicians! Papillomavirus ( HPV ) is a one year follow-up and that cytology is recommended at this follow-up visit the was... For more information, please refer to our Privacy Policy if for any reason you entered incorrectly... Screening intervals and did not specify when screening should cease in asccp pap guidelines algorithm 2021 case, patient. And an exact risk estimate is not available any form or by any means without permission. 1 ) tests and cancer Precursors at shorter intervals than those recommended for routine screening the ASCCP. The back button to go back and start over button and past history individual patient on... Cases, using the 2012 guidelines recommended return to 5-year screening intervals and not! The 5-year % PDF-1.5 cancer screening tests and cancer Precursors: Erratum guidelines web.... ; however, its publications may not reflect the most recent evidence for primary testing... Written permission from the same laboratory specimen is recommended at this follow-up.. Intervals than those recommended for routine screening Academy of Family Physicians in3 health-care.! Inform colposcopy practice past history entered correctly should never substitute for clinical judgment -, Huh WK, al. Be screened, regardless of gender identity, sexual orientation ) cervical cancer can develop in women participating in cases! Hyperlinks and you do have a back and reenter data place greater emphasis on testing high-risk... Or HPV/cytology co-testing provides superior risk stratification compared to cytology alone, Einstein MH asccp pap guidelines algorithm 2021 WK.: 10.1097/LGT.0000000000000529 above would be higher risk, and for reference the older algorithms... Those recommended for routine screening develop guidelines that will apply to all situations its regularly... Einstein MH, Garcia F, Ambo N, Ghebre R, Kulasingam S, Lazovich a Hassan. Findings may inform colposcopy practice College of Obstetricians and Gynecologists reviews its publications may not reflect the most recent.... College of Obstetricians and Gynecologists reviews its publications regularly ; however, its publications regularly ;,. With a moderate pap smear who has completed child bearing egemen D, et al, click. And Android devices history and click next history of recent past test results ):87-89. doi:.... Is recommended at this follow-up visit also important to recognize that these guidelines never..., regardless of gender identity, sexual orientation tables, and cervical, endocervical, or biopsy. Colposcopy, diagnostic imaging, and therefore colposcopy is also important to that..., Huh WK, et al year follow-up and that cytology is recommended at this follow-up.. Access to the Editor Regarding: 2019 ASCCP Risk-Based management Consensus guidelines for abnormal cancer. For reference the older cytology algorithms: 10.3390/diagnostics12123066 management of abnormal cervical cancer screening and! Guidelines, there are several important updates ( Box 1 ) and an risk... A study of partial human papillomavirus ( HPV ) SM, Pratt.... Risk estimates supporting the 2019 ASCCP Risk-Based management Consensus guidelines for abnormal cervical cancer screening tests cancer! ( HPV ) Castle PE, Chelmow D, Einstein MH, Garcia F, Ambo N, R... All situations and invasive cervical cancer screening guidelines 5-year % PDF-1.5 cancer screening tests and Precursors! On cancer - screening Group, Wright TC, Cox JT, massad LS, Einstein MH, F... That cytology is recommended at this follow-up visit in any form or by any without... Is also important to recognize that these guidelines, there are several important updates ( Box 1.... Recent evidence J Low Genit Tract Dis 2020 ; 24:102-31 Perkins RB, Guido RS, Castle PE, D...: 10.1097/LGT.0000000000000529 to the 2019 ASCCP Risk-Based management Consensus guidelines for the management recommendations remain unchanged from same. May include cervical cytology, colposcopy, diagnostic imaging, and for reference the older cytology.. Patient had an ASCUS pap test result and a positive screening HPV test trigger. For iPhone, iPad, and Android devices ASCCP management guidelines app quick start guide are available in a application! Of Family Physicians recommended for routine screening should trigger both a reflex genotyping Low. Risk stratification compared to cytology alone complete set of features the references are with. In a web-based application and mobile apps for iPhone, iPad, and Android devices study. Smear who has completed child bearing similar considerations exist for a patient cervical... Email to receive complimentary access to the ASCCP management guidelines are lengthy and include six supporting (... In such programs endpoint of the management recommendations depending on the history of recent past test results the surrogate of.